Stay updated with breaking news from Cellular Origin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Closed, fully automated, and configurable robotic platform for cell therapy manufacture can achieve 30-fold increase in space efficiency and reduces production costs and labour by 51% and 16-fold
A closed, fully automated, and configurable robotic platform for cell therapy manufacture can achieve 30-fold increase in space efficiency and reduces production costs and labor by 51% and 16-fold, respectively.
Partnership aims to integrate ScaleReady's CGT manufacturing workflow with Cellular Origins' robotic technology Initially focussed on automation of ScaleReady's G-Rex platform Cellular Origins
Cellular Origins a TTP Company focused on enabling scalable, cost-effective, and efficient manufacture of cell and gene therapies (CGTs).
Cellular Origins has partnered with ScaleReady, to automate portions of its cell and gene therapies (CGT) manufacturing workflow using a robotics system for sterile liquid transfer.